These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
19 related articles for article (PubMed ID: 14920505)
1. Chemical agents in neoplastic diseases; an evaluation of chemotherapeutic substances for clinical management. BIERMAN HR Calif Med; 1953 Jan; 78(1):44-58. PubMed ID: 13009518 [TBL] [Abstract][Full Text] [Related]
2. Pigmented skin lesions; treatment with monobenzyl-ether of hydroquinone. KELLY EW J Mich State Med Soc; 1956 Mar; 55(3):303-4; passim. PubMed ID: 13307208 [No Abstract] [Full Text] [Related]
3. Leukomelanoderma subsequent to the application of monobenzyl ether of hydroquinone; a vitiligoid reaction observed in Colombia and Venezuela. CANIZARES O; URIBE JARAMILLO F; KERDEL VEGAS F AMA Arch Derm; 1958 Feb; 77(2):220-3. PubMed ID: 13497298 [No Abstract] [Full Text] [Related]
4. Hyperpigmentation improved by treatment with monobenzyl ether of hydroquinone. POLLOCK JH Arch Derm Syphilol; 1950 May; 61(5):873-5. PubMed ID: 15411240 [No Abstract] [Full Text] [Related]
5. Treatment of chloasma with monobenzyl ether of hydroquinone. FISHER AA AMA Arch Derm Syphilol; 1951 Nov; 64(5):645-6. PubMed ID: 14867896 [No Abstract] [Full Text] [Related]
6. Pigmentary disturbance following exposure to monobenzyl ether of hydroquinone. BERNSTEIN ET; SACHS PM Arch Derm Syphilol; 1949 May; 59(5):542-8. PubMed ID: 18127502 [No Abstract] [Full Text] [Related]
7. Negative effects of oral monobenzyl ether of hydroquinone in malignant melanoma in man. KELLY KH; BIERMAN HR; SHIMKIN MB Proc Soc Exp Biol Med; 1952 Apr; 79(4):589-90. PubMed ID: 14920505 [No Abstract] [Full Text] [Related]